Ping An Biomedical Co., Ltd. cash flow statement

In fiscal 2025, Ping An Biomedical Co., Ltd.'s operations generated −$891,285 of cash.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Ping An Biomedical Co., Ltd.: cash flow statement, annual
Fiscal year	2023Sept 2023	2024Sept 2024	2025Sept 2025
Cash from operations	−863	2,031	−891
Depreciation and amortisation	5	1	1
Dividends paid	1,362	45	—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Nexttrip, Inc. cash flow
Xcel Brands, Inc. cash flow
Linkage Global Inc cash flow
Lixiang Education Holding Co. Ltd. cash flow
Emerson Radio Corp cash flow

Head to head: NTRP vs PASW PASW vs XELB PASW vs UZX

More: Consumer Discretionary sector, rankings of US companies

Figures from Ping An Biomedical Co., Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Ping An Biomedical Co., Ltd.